Home
Conditions
Urogenital Neoplasms

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,025 public trials 2,564 recruiting studies

Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer

NCT06517901

Conditions: Diagnosis, Disease, Genital Diseases, +12 more
Locations: Lahey Clinic, Inc Burlington, Massachusetts, United States

Albany Medical Center Albany, New York, United States

Pennsylvania State University Hershey, Pennsylvania, United States

Manitoba Prostate Centre, CancerCare Manitoba Winnipeg, Manitoba, Canada

View Trial Details

Recruiting

Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy

NCT06427824

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Recruiting

Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer

NCT06781879

Conditions: Carcinoma, Disease Attributes, Female Urogenital Diseases, +17 more
Locations: Aalborg University Hospital Aalborg, Denmark

Aarhus University Hospital Aarhus N, Denmark

Herlev and Gentofte Hospital Herlev, Denmark

Zealand University Hospital, Roskilde Roskilde, Denmark

View Trial Details

Recruiting

WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC

NCT04644289

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations: Universitätsklinikum Mannheim GmbH, Frauenklinik Mannheim, Baden-Wurttemberg, Germany

Klinikum rechts der Isar, Technische Universität München, Klinik und Poliklinik für Frauenheilkunde München, Bavaria, Germany

Mammazentrum HH am Krankenhaus Jerusalem, Gynäkologisches Operationszentrum Hamburg Hamburg, Free and Hanseatic City of Hamburg, Germany

KEM Essen | Evang. Kliniken Essen Mitte Essen, North Rine-Westphalia, Germany

View Trial Details

Recruiting

Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers

NCT05296564

Conditions: Adnexal Diseases, Bladder Urothelial Carcinoma, Breast Diseases, +54 more
Locations: Hadassah Medical Organization Jerusalem, Israel

View Trial Details

Recruiting

Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors

NCT00722228

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +51 more
Locations: Hadassah Medical Organization Jerusalem, Israel

View Trial Details

Recruiting

Investigation Into the Integration of Intracavitary Cryoablation and Immunotherapy in Bladder-Preserving Therapy

NCT07204132

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: ChangHai Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Validity of Parametric MRI Using VIRADS

NCT05783271

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Assuit university Asyut, Assuit, Egypt

View Trial Details

Recruiting

Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer

NCT05346848

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Sainte Catherine, Institut du Cancer Avignon-Provence Avignon, France

CHRU Besançon Besançon, France

Institut Bergonie Bordeaux, France

CHRU Brest - Hôpital Morvan Brest, France

View Trial Details

Recruiting

Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients

NCT06824818

Conditions: Elderly, Genital Diseases, Genital Diseases, Male, +9 more
Locations: The University of Illinois at Chicago (UIC) Chicago, Illinois, United States

UChicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Urogenital Neoplasms

Urogenital Neoplasms trial results

Related conditions